RhumbLine Advisers’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-54,641
| Closed | -$310K | – | 4169 |
|
|
2025
Q3 | $310K | Buy |
54,641
+141
| +0.3% | +$722 | ﹤0.01% | 2975 |
|
|
2025
Q2 | $208K | Buy |
54,500
+3,001
| +6% | +$9.32K | ﹤0.01% | 3211 |
|
|
2025
Q1 | $135K | Buy |
51,499
+8,945
| +21% | +$29.1K | ﹤0.01% | 3287 |
|
|
2024
Q4 | $151K | Buy |
42,554
+7,112
| +20% | +$27.2K | ﹤0.01% | 3332 |
|
|
2024
Q3 | $162K | Sell |
35,442
-2,488
| -7% | -$12K | ﹤0.01% | 3334 |
|
|
2024
Q2 | $165K | Buy |
37,930
+1,489
| +4% | +$6.54K | ﹤0.01% | 3332 |
|
|
2024
Q1 | $183K | Buy |
36,441
+756
| +2% | +$4.24K | ﹤0.01% | 3224 |
|
|
2023
Q4 | $224K | Buy |
35,685
+767
| +2% | +$4.39K | ﹤0.01% | 3124 |
|
|
2023
Q3 | $249K | Buy |
34,918
+956
| +3% | +$7.53K | ﹤0.01% | 3036 |
|
|
2023
Q2 | $346K | Buy |
+33,962
| New | +$354K | ﹤0.01% | 2923 |
|